Xiaodi Yan
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Co-authors
- Dengfu Yao (6 shared papers)Juan Wei (2 shared papers)Ninghua Yao (5 shared papers)Min Yao (5 shared papers)Liang Xiao (1 shared paper)Yuanli Chen (1 shared paper)Liwei Qiu (4 shared papers)Ming Zhong (1 shared paper)
- Journals
- Tumor Biology (4 papers)Life Sciences (2 papers)European Journal of Pharmacology (1 paper)ACS Omega (1 paper)Current Pharmaceutical Design (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Xiaodi Yan
27 papers receiving 460 citations
Peers
Comparison fields: 5 of 61
- Hepatology 77
- Cancer Research 54
- Molecular Biology 194
- Pharmacology 17
- Epidemiology 50
Countries citing papers authored by Xiaodi Yan
This map shows the geographic impact of Xiaodi Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodi Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodi Yan more than expected).
Fields of papers citing papers by Xiaodi Yan
This network shows the impact of papers produced by Xiaodi Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodi Yan. The network helps show where Xiaodi Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaodi Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of hepatic cells pyroptosis attenuates CLP-induced acute liver injury. | 2016 | 84 |
| 2 | 2017 | 48 | |
| 3 | 2013 | 43 | |
| 4 | 2018 | 30 | |
| 5 | 2021 | 27 | |
| 6 | 2012 | 25 | |
| 7 | 2020 | 24 | |
| 8 | 2025 | 24 | |
| 9 | 2021 | 21 | |
| 10 | 2013 | 17 | |
| 11 | TLR4-dependent internalization of CX3CR1 aggravates sepsis-induced immunoparalysis. | 2016 | 14 |
| 12 | 2012 | 13 | |
| 13 | 2022 | 13 | |
| 14 | 2013 | 9 | |
| 15 | 2021 | 9 | |
| 16 | 2022 | 9 | |
| 17 | 2019 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2016 | 7 | |
| 20 | 2019 | 6 |
About Xiaodi Yan
Xiaodi Yan is a scholar working on Cancer Research, Hepatology, Endocrinology, Diabetes and Metabolism, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 465 indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Single-cell and spatial transcriptomics (2 papers), Effects of Radiation Exposure (2 papers), Developmental Biology and Gene Regulation (2 papers) and Sepsis Diagnosis and Treatment (1 paper). The work is most often cited by research in Hepatology (77 citations), Cancer Research (54 citations), Molecular Biology (194 citations), Pharmacology (17 citations) and Epidemiology (50 citations). Xiaodi Yan has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Dengfu Yao, Juan Wei, Ninghua Yao, Min Yao, Liang Xiao, Yuanli Chen, Liwei Qiu, Ming Zhong, Xin Lv and Wenli Sai. Their work appears in journals such as Tumor Biology, Life Sciences, European Journal of Pharmacology, ACS Omega and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.